OKYO Pharma Limited (OKYO)

NASDAQ

$1.42

$--

(0.00%)

Pre-Market

OKYO Pharma Limited (OKYO) Live Price Chart

Last updated: ⁦2026-10-13 10:26:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

OKYO Pharma Limited (OKYO) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.42, with a market capitalisation of $74.52M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.26 to $3.20. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$74.52M
Open	$1.42
Day's High	$7.00
Day's Low	$0.81
Previous Close	$1.44
Volume	--
Average Volume	93.32K
P/E Ratio	--
52-Week High	$3.20
52-Week Low	$1.26
Dividend Yield	--
Earnings Date	--

OKYO Pharma Limited (OKYO) Pre-Market Stock Price

OKYO Pharma Limited (OKYO) is trading at $1.42 in pre-market trading as of 2026-10-13 08:02:00, down 1.74% ($0.02) from the previous close of $1.44

Pre-market trading shows how investors are pricing OKYO before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

OKYO Pharma Limited (OKYO) 7-Day Stock Price Change

Over the past seven days, OKYO Pharma Limited (OKYO) moved from $1.47 to $1.42, representing a decline of 3.74% ($0.05).

The stock traded between $1.33 and $1.53 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 53.06 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

OKYO 52-Week Price Position

Position in Range: 7.8%

52W Low$1.26

52W High$3.20

OKYO is currently trading at $1.42, placing it 7.8% of the way from its 52-week low of $1.26 to its 52-week high of $3.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is OKYO Pharma Limited (OKYO)?

OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.

OKYO Pharma Limited Information

Employees	5
Exchange	NASDAQ
Company Website	https://www.okyopharma.com

How to Buy OKYO Pharma Limited (OKYO) Stock on MEXC

Eligible investors can buy real shares of OKYO Pharma Limited (OKYO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for OKYO and Place Your Order

Open the RealStocks trading page and search for OKYO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is OKYO Pharma Limited (OKYO) stock price today?

OKYO Pharma Limited (OKYO) is currently trading at $ 1.42, down 1.74% ($0.02) from the previous close of $ 1.44. Intraday prices update in real time during regular trading hours.

2.Is OKYO stock going up or down today?

As of 2026-10-13 08:02:00, OKYO is trading at $ 1.42, down 1.74% ($0.02) from its previous close of $ 1.44. The stock has traded between $ 0.81 and $ 7.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is OKYO pre-market price?

As of 2026-10-13 08:02:00, OKYO is trading at $ 1.42 in pre-market trading, down 1.74% ($0.02) from the previous close of $ 1.44. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is OKYO after-hours price?

As of 2026-10-13 08:02:00, OKYO is trading at $ 1.41 in after-hours trading, down 1.81% ($0.03) from the regular-session close of $ 1.44. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is OKYO stock trading now?

OKYO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does OKYO sit relative to its 52-week high and low?

Over the past 52 weeks, OKYO has traded between a low of $ 1.26 and a high of $ 3.20. At $ 1.42, the stock is positioned 7.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is OKYO Pharma Limited in?

OKYO Pharma Limited (OKYO) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is OKYO Pharma Limited's market capitalisation and where is it listed?

OKYO Pharma Limited is listed on the NASDAQ exchange with a market capitalisation of $ 74.52M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is OKYO valued in terms of P/E ratio and EPS?

OKYO trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does OKYO Pharma Limited pay a dividend?

OKYO Pharma Limited pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.